More NewsRead More
Trevena Reports Second Quarter 2014 Financial Results
August 12, 2014
Trevena Initiates Phase 1 Multiple Ascending Dose Study of TRV734 for Acute and Chronic Pain
August 06, 2014
Trevena Granted Key U.S. Method of Use Patent for TRV027
August 05, 2014
Mark H.N. Corrigan, M.D., Julie H. McHugh, and William Hunter, M.D. to Serve on EPIRUS Board of Directors
July 15, 2014
Results of Phase 1b Clinical Trial Comparing Trevena’s TRV130 to Morphine Published in the Journal Pain
June 24, 2014
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here